Latest revenue
$155.4M
as of 2026-03-31
Latest net income
$2.0M
as of 2026-03-31
Net margin
1.3%
as of 2026-03-31
Price · 5Y
Live market
delayed ≤15 min- Market cap
- $1.30B
- Enterprise value
- $1.30B
- P/E (trailing)
- 29.4×
- Forward P/E
- —
- P/B
- —
- Dividend yield
- 1.3%
- 52-wk high
- $48.76
- 52-wk low
- $25.73
- Beta
- —
- Shares out
- 42.8M
5-year trend
What this company does
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS The following discussion and analysis of the financial condition and results of operations of Cadre Holdings, Inc. (D/B/A The Safariland Group) (“Cadre,” “the Company,” “we,” “us” and “our”) should be read in conjunction with our unaudited condensed consolidated financial statements and the related notes appearing elsewhere in this Quarterly Report and with our audited consolidated financial statements included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025. The following discussion contains forward-looking statements that reflect future plans, estimates, beliefs and…
AI summary unavailable — showing raw filing excerpt
Generated from CDRE's filing dated 2026-05-11
Key risks
Item 1A. Risk Factors RISK FACTORS In addition to other information contained in this Annual Report on Form 10-K, the following risk factors should be carefully considered in evaluating our business, because such factors may have a significant impact on our business, operating results, liquidity and financial condition. As a result of the risk factors set forth below, actual results could differ materially from those mentioned in any forward-looking statements. Additional risks and uncertainties not presently known to us, or that we currently consider to be immaterial, may also impact our business, operating results, liquidity and financial condition. If any of the following risks occur,…
AI summary unavailable — showing raw filing excerpt
Generated from CDRE's filing dated 2026-05-11
Profitability
Gross margin
42.5%
3.4%Operating margin
11.0%
6.2%Net margin
7.2%
13.6%Return on equity
14.2%
22.7%Return on assets
5.7%
3.5%Leverage
Debt / equity
1.47×
36.3%Long-term debt / equity
0.93×
13.1%Debt / assets
59.5%
14.7%Earnings tracker
| Quarter | Revenue | YoY | Net income | YoY | Net margin |
|---|---|---|---|---|---|
Q1 2026 2026-03-31 | $155.4M | +19.5% | $2.0M | -78.6% | 1.3% |
Q4 2025 2025-12-31 | $167.2M | -5.0% | $11.7M | -9.6% | 7.0% |
Q3 2025 2025-09-30 | $155.9M | +42.5% | $10.9M | +199.3% | 7.0% |
Q2 2025 2025-06-30 | $157.1M | +8.9% | $12.2M | -2.8% | 7.8% |
Q1 2025 2025-03-31 | $130.1M | -5.6% | $9.2M | +33.5% | 7.1% |
Q4 2024 2024-12-31 | $176.0M | — | $13.0M | — | 7.4% |
Q3 2024 2024-09-30 | $109.4M | -12.6% | $3.7M | -66.9% | 3.3% |
Q2 2024 2024-06-30 | $144.3M | +19.2% | $12.6M | +14.3% | 8.7% |
Year-over-year change vs the same fiscal quarter one year prior. Revenue + net income sourced from SEC 10-Q / 10-K filings — no analyst-consensus dependency.
Industry trend
Orthopedic, Prosthetic & Surgical Appliances & Supplies · SIC 3842
Your notes
Keep private notes on CDRE — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
Insider activity
Insider buying
$0
Insider selling
$75.7M
Net activity
−$75.7M
Distinct insiders
3
Open-market trades over the last 365 days.
Recent transactions
Source: SEC Form 4 filings. Officers, directors, and 10%+ owners must disclose share transactions within two business days. RSU grants and tax-withholding rows are excluded by default — compensation activity is not a trading signal.
Who owns CDRE
Institutional value
$436.7M
Total shares held
15.6M
Distinct holders
97
-62 vs prior
As of
2026-03-31
Prior: 2025-12-31
Filers with $100M+ AUM disclose holdings 45 days after quarter end.
Top institutional holders
| # | Manager | Shares | Value | QoQ change | Action |
|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 2.6M | $80.6M | -27.8K (-1.0%) | Trimmed |
| 2 | REINHART PARTNERS, LLC. | 2.2M | $68.7M | +67.5K (+3.1%) | Added |
| 3 | Capital International Investors | 1.3M | $38.7M | -1.1M (-45.7%) | Trimmed |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 1.2M | $38.3M | — | New |
| 5 | Capital World Investors | 1.2M | $36.0M | — | New |
| 6 | DIMENSIONAL FUND ADVISORS LP | 767.1K | $23.5M | +60.4K (+8.5%) | Added |
| 7 | Capital Research Global Investors | 588.3K | $18.0M | -255.2K (-30.3%) | Trimmed |
| 8 | UBS Group AG | 353.4K | $10.8M | +126.3K (+55.6%) | Added |
| 9 | Invesco Ltd. | 289.8K | $8.9M | +44.8K (+18.3%) | Added |
| 10 | Catawba River Capital | 260.3K | $8.4M | -199.0K (-43.3%) | Trimmed |
| 11 | JPMORGAN CHASE & CO | 240.5K | $7.1M | +55.4K (+29.9%) | Added |
| 12 | WCM INVESTMENT MANAGEMENT, LLC | 237.2K | $7.0M | -134.4K (-36.2%) | Trimmed |
| 13 | FIRST TRUST ADVISORS LP | 223.9K | $6.9M | +107.6K (+92.6%) | Added |
| 14 | AGMAN CAPITAL LLC | 213.7K | $6.6M | +33.4K (+18.5%) | Added |
| 15 | VANGUARD PORTFOLIO MANAGEMENT LLC | 204.5K | $6.3M | — | New |
| 16 | VANGUARD FIDUCIARY TRUST CO | 198.8K | $6.1M | — | New |
| 17 | WELLS FARGO & COMPANY/MN | 183.1K | $5.6M | -17.1K (-8.6%) | Trimmed |
| 18 | Russell Investments Group, Ltd. | 166.4K | $5.1M | +70.0K (+72.7%) | Added |
| 19 | Bank of New York Mellon Corp | 165.3K | $5.1M | +3.0K (+1.8%) | Added |
| 20 | DEPRINCE RACE & ZOLLO INC | 159.9K | $4.9M | +71.0K (+79.8%) | Added |
Source: SEC Form 13F-HR. Positions aggregated across sub-managers within each firm. Options (puts/calls) excluded — common stock only.
Top questions investors are asking
Coming once CDRE's latest filing finishes processing.